Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: A prospective 2-year study

Cancer

Volumn 117, Issue 15, 2011, Pages 3424-3433

  Sampsonas, Fotis ^a   Kontoyiannis, Dimitrios P ^a   Dickey, Burton F ^a   Evans, Scott E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

bronchoalveolar lavage; cancer; diagnosis; immunocompromise; pneumonia

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; OXYHEMOGLOBIN; SODIUM CHLORIDE;

ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRONCHOSCOPY; CANDIDA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS; HEMATOLOGIC MALIGNANCY; HUMAN; HYPOXEMIA; INFLUENZA A; INFLUENZA B; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG HEMORRHAGE; LUNG INFECTION; LUNG INFILTRATE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEOPLASM; NEUTROPENIA; NOCARDIA; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SINUS TACHYCARDIA; SOLID TUMOR; STANDARDIZATION; STENOTROPHOMONAS MALTOPHILIA;

EID: 79960210611     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25905     Document Type: Article

References (32)

1. Rolston KV, Bodey GP, Safdar A,. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis. 2007; 45: 228-233. (Pubitemid 47041015)
2. Maschmeyer G, Beinert T, Buchheidt D, et al. Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2003; 82 (suppl 2): S118-S126. (Pubitemid 37265298)
3. Joos L, Tamm M,. Breakdown of pulmonary host defense in the immunocompromised host: cancer chemotherapy. Proc Am Thorac Soc. 2005; 2: 445-448. (Pubitemid 43128041)
4. Elting LS, Rubenstein EB, Rolston KV, Bodey GP,. Outcomes of bacteremia in patients with cancer and neutropenia: observations from 2 decades of epidemiological and clinical trials. Clin Infect Dis. 1997; 25: 247-259. (Pubitemid 27364722)
5. Klech H, Pohl W,. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Res J. 1989; 2: 561-585. (Pubitemid 19170588)
6. Goldstein RA, Rohatgi PK, Bergofsky EH,. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis. 1990; 142: 481-486. (Pubitemid 20235965)
7. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002; 34: 7-14. (Pubitemid 33152659)
8. Lionakis MS, Kontoyiannis DP,. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer. 2004; 100: 165-172.
9. Kuehnhardt D, Hannemann M, Schmidt B, Heider U, Possinger K, Eucker J,. Therapeutic implication of BAL in patients with neutropenia. Ann Hematol. 2009; 88: 1249-1256.
10. Von Eiff M, Zuhlsdorf M, Roos N, Thomas M, Buchner T, van de Loo J,. Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures. Eur J Haematol. 1995; 54: 157-162.
11. Cordonnier C, Bernaudin JF, Fleury J, et al. Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation. Am Rev Respir Dis. 1985; 132: 1118-1123. (Pubitemid 16221407)
12. Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC,. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest. 2004; 125: 712-722. (Pubitemid 38223654)
13. Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP,. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010; 45: 647-655.
14. Hummel M, Rudert S, Hof H, Hehlmann R, Buchheidt D,. Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates. Ann Hematol. 2008; 87: 291-297. (Pubitemid 351445290)
15. Azoulay E, Mokart D, Rabbat A, et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med. 2008; 36: 100-107.
16. Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006; 43: 577-584. (Pubitemid 44267116)
17. Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis. 2009; 49: 1688-1693.
18. Aquino VR, Goldani LZ, Pasqualotto AC,. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia. 2007; 163: 191-202. (Pubitemid 46625370)
19. Inai K, Iwasaki H, Noriki S, et al. Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies. Int J Hematol. 2007; 86: 225-232. (Pubitemid 350085811)
20. Kontoyiannis DP, Reddy BT, Torres HA, et al. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis. 2002; 34: 400-403. (Pubitemid 34062244)
21. Leventakos K, Lewis RE, Kontoyiannis DP,. Fungal infections in leukemia patients: how do we prevent and treat them ? Clin Infect Dis. 2010; 50: 405-415.
22. Chandrasekar PH, Ramesh M,. Challenges in the management of invasive aspergillosis in hematopoietic stem cell transplantation. Expert Rev Anti Infect Ther. 2009; 7: 1151-1153.
23. Haslam PL, Baughman RP,. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J. 1999; 14: 245-248. (Pubitemid 29461283)
24. Meyer KC,. Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med. 2007; 28: 546-560. (Pubitemid 350036965)
25. Rosell A, Xaubet A, Agusti C, et al. RASTA Study Group. A new BAL fluid instillation and aspiration technique: a multicenter randomized study. Respir Med. 2006; 100: 529-535. (Pubitemid 43245409)
26. Bergeron A, Belle A, Sulahian A, et al. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest. 2010; 137: 410-415.
27. Francesconi A, Kasai M, Petraitiene R, et al. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol. 2006; 44: 2475-2480. (Pubitemid 44092414)
28. Hsu LY, Ding Y, Phua J, et al. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect Dis. 2010; 10: 44-49.
29. Klont RR, Mennink-Kersten MASH,., Verweij PE,. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis. 2004; 39: 1467-1474. (Pubitemid 39518210)
30. Rano A, Agusti C, Jimenez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax. 2001; 56: 379-387. (Pubitemid 32398129)
31. Pinckard JK, Kollef M, Dunne WM,. Culturing bronchial washings obtained during bronchoscopy fails to add diagnostic utility to culturing the bronchoalveolar lavage fluid alone. Diagn Microbiol Infect Dis. 2002; 43: 99-105. (Pubitemid 34667079)
32. Vandewoude KH, Blot SI, Depuydt P, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients [serial online]. Crit Care. 2006; 10: R31.